Name | methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-(trifluoromethyl)benzoate |
---|---|
Synonyms |
BENZOIC ACID,2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-5-(TRIFLUOROMETHYL)-,METHYL ESTER
2-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-5-(TRIFLUOROMETHYL)-BENZOIC ACID,METHYL ESTER CF3(C6H3)C(O)OMe(Bpin) methyl 5-trifluoromethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-benzoate methyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-trifluoromethylbenzoate 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5-trifluoropmethylbenzoic acid methyl ester |
Molecular Formula | C15H18BF3O4 |
---|---|
Molecular Weight | 330.10700 |
Exact Mass | 330.12500 |
PSA | 44.76000 |
LogP | 2.79120 |
~11% 873846-89-0 |
Literature: NOVARTIS AG; NOVARTIS PHARMA GMBH Patent: WO2006/136442 A1, 2006 ; Location in patent: Page/Page column 90-91 ; WO 2006/136442 A1 |
~94% 873846-89-0 |
Literature: Ishiyama, Tatsuo; Isou, Hironori; Kikuchi, Takao; Miyaura, Norio Chemical Communications, 2010 , vol. 46, # 1 p. 159 - 161 |
Precursor 3 | |
---|---|
DownStream 0 |